NCT07163039 · NOT YET RECRUITING

The Effect of Dual Task Training on Cognitive in Alzheimer's Disease

This trial compares two kinds of exercise in people already diagnosed with mild Alzheimer's: dual-task training, which combines movement with thinking tasks, and conventional exercise. Over 8 weeks, researchers will measure memory and thinking, mobility, balance, and quality of life. It has no phase label because it tests a training method, not a drug.

You may qualify if

  • Age ≥ 60 years
  • Diagnosed with mild-stage Alzheimer's disease (According to DSM-5 or NINCDS-ADRDA criteria)
  • MoCA score between 10-25 (Indicating sufficient cognitive capacity for dual-task training)
  • Ability to walk independently or with minimal assistance
  • Adequate hearing and vision to enable communication
  • Physical and mental capacity to participate in the dual-task training protocol
  • Provision of written informed consent (signed informed consent form)

You're excluded if

  • Diagnosis of advanced-stage Alzheimer's disease (MoCA \< 10)
  • Presence of additional neurological disorders affecting the motor system (e.g. Parkinson's disease, stroke, multiple sclerosis)
  • Severe hearing or vision impairment (inability to respond to visual or auditory stimuli)
  • History of psychiatric disorders (e.g., major depression, schizophrenia)
  • Orthopedic or cardiopulmonary conditions that would prevent participation in dual-task training
  • Participation in another cognitive or physical rehabilitation program within the last 3 months
  • Individuals with unstable cognitive status due to recent medication changes

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-09-09

View full record on ClinicalTrials.gov

All APOE4 clinical trials